How can something be declared a breakthrough one minute and not a viable treatment the next? The science was clear:
1⃣ 71% of phase 3 trial participants no longer qualified for PTSD diagnosis after MDMA-assisted therapy.
2⃣ 86% of trial participants experienced a reduction in symptoms.
3⃣ MDMA-AT had almost DOUBLE the efficacy of existing treatments.
Today’s FDA decision is disgraceful and is a missed opportunity to embrace groundbreaking science, save countless veteran lives, and honor the sacrifices made by those who served our country. We are undeterred and will continue working to bring MDMA-AT to fruition. In the meantime, 13 million Americans will continue to suffer from PTSD, and more than 17 veterans will continue to die by suicide every day.
@US_FDA,
@DrCaliff_FDA, shame on you. Read our full statement here:
heroicheartsproject.org/resp…